Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
17.90
-1.01 (-5.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
NVCR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead the NovoCure Class Action Lawsuit
June 20, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
NOVOCURE LIMITED (NASDAQ: NVCR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against NovoCure Limited
June 20, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm
June 20, 2023
From
The Schall Law Firm
Via
Business Wire
The Latest Analyst Ratings for NovoCure
June 06, 2023
Via
Benzinga
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm
June 19, 2023
From
The Schall Law Firm
Via
Business Wire
NOVOCURE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the Firm
June 19, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors
June 16, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
Why NovoCure Stock Is Crashing Today
June 06, 2023
Analysts weren't wowed by the company's late-stage data.
Via
The Motley Fool
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into NovoCure Limited (NVCR)
June 16, 2023
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors
June 15, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of NovoCure Limited (NVCR) on Behalf of Investors
June 15, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon
June 12, 2023
These three small cap drug companies could become gold or lead depending on the outcomes of their clinical trials.
Via
InvestorPlace
This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street
June 12, 2023
A big turnaround could be in the cards for this medical device maker.
Via
The Motley Fool
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
June 09, 2023
The Nasdaq held near 52-week highs while small caps ramped up.
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Wednesday
June 07, 2023
On Wednesday, 29 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
June 07, 2023
Via
Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm
June 07, 2023
From
The Schall Law Firm
Via
Business Wire
These 2 Nasdaq Stocks Are Plunging. Here's Why
June 06, 2023
Tuesday brought optimism to the stock market overall, but not for these companies.
Via
The Motley Fool
Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher
June 06, 2023
U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.36% to 33,440.78 while the NASDAQ rose 0.09% to 13,241.04. The S&P 500,...
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the Firm
June 06, 2023
From
The Schall Law Firm
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
June 06, 2023
On Tuesday, 69 stocks hit new 52-week lows.
Via
Benzinga
Stocks Mixed As VIX Extends Lows
June 06, 2023
Stocks are struggling for direction midday.
Via
Talk Markets
Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts
June 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 06, 2023
Via
Benzinga
Nasdaq Edges Higher; Joann Shares Plummet
June 06, 2023
U.S. stocks traded mixed midway through trading, with Nasdaq Composite turning higher on Tuesday. The Dow traded down 0.08% to 33,534.50 while the NASDAQ rose 0.27% to 13,265.27. The S&P 500, also...
Via
Benzinga
Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday
June 06, 2023
U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 06, 2023
Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.
Via
Benzinga
Novocure Crashes Almost 30% As Critics Question Its 'Profound' Impact In Lung Cancer Treatment
June 06, 2023
Novocure said its device, Optune, extended overall survival by more than three months for some lung cancer patients.
Via
Investor's Business Daily
Dow Drops 50 Points; J.M. Smucker Earnings Top Views
June 06, 2023
U.S. stocks traded lower this morning, with Dow Jones dropping around 50 points on Monday. The Dow traded down 0.16% to 33,509.87 while the NASDAQ fell 0.19% to 13,203.91. The S&P 500, also fell,...
Via
Benzinga
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
June 06, 2023
From
Zai Lab Limited
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.